Interactions between ibuprofen, ACE2, renin-angiotensin system, and spike protein in the lung. Implications for COVID-19
- PMID: 33931961
- PMCID: PMC8019581
- DOI: 10.1002/ctm2.371
Interactions between ibuprofen, ACE2, renin-angiotensin system, and spike protein in the lung. Implications for COVID-19
Conflict of interest statement
The authors declare that there is no conflict of interest.
Figures
Similar articles
-
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2.Circ Res. 2021 Apr 30;128(9):1323-1326. doi: 10.1161/CIRCRESAHA.121.318902. Epub 2021 Mar 31. Circ Res. 2021. PMID: 33784827 Free PMC article. No abstract available.
-
Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections.Laryngoscope. 2021 Mar;131(3):E932-E939. doi: 10.1002/lary.29132. Epub 2020 Oct 19. Laryngoscope. 2021. PMID: 32940922
-
Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction.Signal Transduct Target Ther. 2021 May 18;6(1):198. doi: 10.1038/s41392-021-00619-y. Signal Transduct Target Ther. 2021. PMID: 34006835 Free PMC article. No abstract available.
-
Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.Adv Chronic Kidney Dis. 2020 Sep;27(5):404-411. doi: 10.1053/j.ackd.2020.07.002. Epub 2020 Jul 4. Adv Chronic Kidney Dis. 2020. PMID: 33308506 Free PMC article. Review.
-
The Controversy of Renin-Angiotensin-System Blocker Facilitation Versus Countering COVID-19 Infection.J Cardiovasc Pharmacol. 2020 Oct;76(4):397-406. doi: 10.1097/FJC.0000000000000894. J Cardiovasc Pharmacol. 2020. PMID: 32769760 Review.
Cited by
-
Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease.PLoS One. 2021 Aug 4;16(8):e0255335. doi: 10.1371/journal.pone.0255335. eCollection 2021. PLoS One. 2021. PMID: 34347801 Free PMC article.
-
Angiotensin System Autoantibodies Correlate With Routine Prognostic Indicators for COVID-19 Severity.Front Med (Lausanne). 2022 Mar 9;9:840662. doi: 10.3389/fmed.2022.840662. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35355599 Free PMC article.
-
Structural biology of SARS-CoV-2: open the door for novel therapies.Signal Transduct Target Ther. 2022 Jan 27;7(1):26. doi: 10.1038/s41392-022-00884-5. Signal Transduct Target Ther. 2022. PMID: 35087058 Free PMC article. Review.
-
Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment.Biomedicines. 2022 Feb 21;10(2):502. doi: 10.3390/biomedicines10020502. Biomedicines. 2022. PMID: 35203711 Free PMC article. Review.
-
COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges.Cells. 2021 Nov 24;10(12):3291. doi: 10.3390/cells10123291. Cells. 2021. PMID: 34943795 Free PMC article. Review.
References
-
- Wu R, Laplante MA, de Champlain J. Cyclooxygenase‐2 inhibitors attenuate angiotensin II‐induced oxidative stress, hypertension, and cardiac hypertrophy in rats. Hypertension. 2005;45:1139‐1144. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical